PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
DBCAT005748Pharmacologic class
A DrugBank category of 10 drugs. 9 of them are approved.
What you can answer from here — as of August 31, 2022
Which targets do PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account